Electromed

Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The firm's products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Electromed reports record Q1 revenues, faces CMS waiver expiration

Electromed delivered robust financial performance, driven by strong revenue growth and operational efficiency. The company faces challenges related to potential CMS waiver expiration and CEO succession, but strategic initiatives and market opportunities position it for continued growth. Overall, Electromed's focus on innovation and market expansion bodes well for future success.

Electromed reports record Q2 revenue, focuses on strategic growth

Electromed's Q2 2023 earnings call showcased strong financial performance, particularly in the home care segment. Despite challenges from the expiration of the CMS waiver, the company's strategic growth initiatives and clinical evidence present promising opportunities for future success.

Electromed Inc. reports robust Q3 earnings and targets market expansion

Electromed Inc. delivered strong financial performance in Q3 2023, driven by revenue growth and improved operational efficiency. The company's strategic initiatives and focus on quality assurance position it for continued success. However, managing expenses and balancing revenue across segments will be crucial for sustained growth.

Electromed (ELMD) reports record revenue and eyes growth opportunities

Electromed's Q4 2023 earnings call showcased impressive financial performance, with record revenue and operating income. The company's strategic focus on growth investments, operational excellence, and market development is driving strong results. While facing challenges in optimizing capital deployment, Electromed is well-positioned to leverage opportunities in expanding its market presence and driving further growth.

Electromed (ELMD) achieves record revenue in Q3 2024 earnings call

Electromed (ELMD) delivered robust financial performance in Q3 2024, driven by revenue growth and operational excellence. Despite challenges like a cyberattack and increased expenses, the company remains well-positioned with a strong cash position and growth strategies in place.

Electromed (ELMD) achieves record revenue and market expansion in Q4 2024

Electromed's Q4 2024 performance reflects strong revenue growth, operational excellence, and strategic market initiatives.
While facing challenges in maintaining growth momentum, the company's focus on innovation and market expansion positions it for future success.
With a solid financial position, diverse product portfolio, and growth strategies in place, Electromed is poised for continued growth and market leadership.

Electromed (ELMD) reports robust Q1 earnings and strategic growth plans

Electromed's Q1 2025 performance reflects strong revenue growth, improved profitability, and strategic investments in key areas.
The company's financial stability, operational efficiency, and focus on market expansion position them for sustained success in the medical device industry.
While challenges in maintaining growth persist, Electromed's proactive approach to innovation and market awareness presents opportunities for future expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 first quarter ended September 30, 2021, on Tuesday, November 9, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by d

Electromed, Inc. Schedules its First Quarter Fiscal 2022 Financial Results Conference Call for November 9, 2021 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will nominate two new independent directors, Kathy Tune and Joe Galatowitsch, for election to its Board of Directors at the Company's Fiscal 2022 Annual Meeting of Shareholders (the “Annual Meeting”), to be held in November. In connection with these nominations, Electromed has entered into a cooperation agreemen

Electromed, Inc. Announces Nominations of Kathy Tune and Joe Galatowitsch as New Independent Directors

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the 2021 Colliers Institutional Investor Conference, which will be held virtually, on Thursday, September 9, 2021. About Electromed, Inc. Electromed manufactures, markets, and sells p

Electromed, Inc. to Participate in the 2021 Colliers Institutional Investor Conference

Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q4 2021 Results - Earnings Call Transcript

Electromed, Inc. (ELMD) delivered earnings and revenue surprises of 0.00% and 1.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Electromed, Inc. (ELMD) Q4 Earnings Meet Estimates

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months (“Q4 FY 2021”) and full year (“FY 2021”) ended June 30, 2021. Q4 FY 2021 Financial Highlights Net revenue increased 37.7% to $9.5 million, from $6.9 million for the three months ended June 30, 2020 (“Q4 FY 2020”), driven by 33.6% home care revenue growth and 90.6% growth in institu

Electromed, Inc. Announces Fiscal 2021 Fourth Quarter and Full Year Financial Results

Electromed, Inc. (ELMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Electromed, Inc. (ELMD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 fourth quarter ended June 30, 2021, on Tuesday, August 24, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialin

Electromed, Inc. Schedules its Fourth Quarter Fiscal 2021 Financial Results Conference Call for August 24, 2021 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today confirmed that Summers Value Partners has provided notice of its intent to nominate four candidates to stand for election to the Electromed Board of Directors at its Fiscal 2022 Annual Meeting of Shareholders (the “Annual Meeting”). Members of Electromed's Board and management team have been engaged in an ongoing dialogue with Su

Electromed, Inc. to Consider Director Nominations from Summers Value Partners

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced select preliminary unaudited financial results for the three months ended June 30, 2021 (“Q4 FY 2021”). For Q4 FY 2021, the Company expects to report: Net revenue of between $9.3 million and $9.5 million, compared to $6.9 million for the three months ended June 30, 2020 (“Q4 FY 2020”), driven primarily by strong growth

Electromed, Inc. Announces Select Preliminary Unaudited Financial Results for Fourth Quarter Fiscal 2021

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in Canaccord Genuity's 41st Annual Growth Conference, to be held virtually, on August 10-12, 2021. Below are the details for Electromed's group presentation: Date: Wednesday, August 11,

Electromed, Inc. to Participate in Canaccord Genuity's 41st Annual Growth Conference

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has approved a $3.0 million stock repurchase authorization, effective as of May 26, 2021. Under the authorization, the Company may repurchase common stock, par value $0.01 per share, with an aggregate value of up to $3.0 million through May 26, 2022. The authorization does not obligate the Co

Electromed, Inc. Announces Authorization of $3.0 Million Stock Repurchase Program

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE American: ELMD) was named Quality Magazine's 2021 Plant of the Year. Electromed was selected for the honor from the 2021 Quality Leadership Top 100 Company survey published annually by the magazine. The metrics measure and showcase quality leadership such as: continuous improvement and internal quality programs; contribution of quality to profitability and shareholder value; average number of hours that employees receive quality trainin

Electromed, Inc. Named 2021 Quality Plant of the Year

Electromed, Inc.'s (ELMD) CEO Kathleen Skarvan on Q3 2021 Results - Earnings Call Transcript

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced its financial results for the three months ended March 31, 2021 (“Q3 FY 2021”). Q3 FY 2021 Highlights Net revenue increased 0.5% to $8.8 million, compared to $8.7 million during the three months ended March 31, 2020 (“Q3 FY 2020”), driven by a 4.2% increase in home care revenue. Gross profit percentage increased to 76.3

Electromed, Inc. Announces Fiscal 2021 Third Quarter Financial Results

Electromed, Inc. (ELMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Electromed, Inc. (ELMD) Q3 Earnings Expected to Decline

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 third quarter ended March 31, 2021, on Tuesday, May 11, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing:

Electromed, Inc. Schedules its Third Quarter Fiscal 2021 Financial Results Conference Call for May 11, 2021 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the Sidoti Spring 2021 Virtual Investor Conference on March 24-25, 2021. Management will be available for one-on-ones throughout both days. Below are the details for Electromed's grou

Electromed, Inc. to Participate in the Sidoti Spring 2021 Virtual Investor Conference

Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q2 2021 Results - Earnings Call Transcript

Electromed, Inc. (ELMD) delivered earnings and revenue surprises of 225.00% and 15.10%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Electromed, Inc. (ELMD) Q2 Earnings and Revenues Top Estimates

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2020 (“Q2 FY 2021”). Q2 FY 2021 Highlights Net revenue increased 11.1% to $9.5 million, compared to $8.5 million during the three months ended December 31, 2019 (“Q2 FY 2020”), driven by a 16.1% increase in home care revenue. Gross profit percentage increased to

Electromed, Inc. Announces Fiscal 2021 Second Quarter Financial Results

Earnings Preview: Electromed, Inc. (ELMD) Q2 Earnings Expected to Decline

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 second quarter ended December 31, 2020 on Tuesday, February 9, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by di

Electromed, Inc. Schedules its Second Quarter Fiscal 2021 Financial Results Conference Call for February 9, 2021 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its shareholders have elected Andrea M. Walsh to serve as an additional director of the Company. Since 2017, Ms. Walsh has served as President and CEO of HealthPartners, a Minnesota-based non-profit integrated health system caring for 1.2 million patients and providing health insurance and well-being support to 1.8

Andrea M. Walsh Elected to Electromed, Inc. Board of Directors

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to present at the Sidoti Virtual Microcap Conference on Thursday, November 19, 2020, at 2:30 p.m. Eastern Time. Electromed's presentation will be webcast live and available in the investor relations se

News for Electromed Stock (ELMD)